Thank you for considering to present your work as a poster at Phages 2014.

Please prepare your poster in A1 portrait format (59cm wide x 84cm long). Please do not laminate your poster. Further information about poster sizes can be found on the following link:

http://tinyurl.com/y7bf

Posters larger than A1 will only be displayed subject to the availability of space.

Maximum capacity 30 A1 potrait posters

Please ensure you have appropriate permissions for the publication of your abstract from the original copyright holders. Should you wish your abstract not to be published, please notify us in writing at the time of abstract submission.

Poster presenters will be required to send us their poster as PDF at least two weeks before the event. The posters will be made available via the event website or other electronic media after the event (see copyright information).

>>Where can I print my poster in Oxford?

Posters will be displayed for the full duration of the conference.Titles of accepted poster abstracts will be displayed below.

Accepted posters

(Presenters in Bold)

If your abstract has been accepted for presentation but it does not appear in the list below, please let us know as soon as possible by email on PhageOxford@gmail.com.

Isolation and Characterization of Propionibacterium acnes bacteriophages as alternative therapeutics for treating acne vulgaris

Jenna Graham^1,2*, Reza Nokhbeh², Lyne Giroux³, Sharon Laughlin⁴ and Francisco Diaz-Mitoma²

¹Masters of Science Biology Program- Department of Biology, Laurentian University, 935 Ramsey Lake Road, Sudbury ON P3E2C6, Canada

²Advanced Medical Research Institute of Canada (AMRIC), Health Science North, 41 Ramsey Lake Road, Sudbury ON P3E5J1, Canada

³Sudbury Skin Clinique, 366 Pine Street, Suite 400, Sudbury ON P3C1X8, Canada

⁴Laserderm, 1600 Carling Avenue, Suite 650, Ottawa ON K1Z1G3, Canada

Vibrio harveyi infection in cultured common dentex (Dentex dentex) and greater amberjack (Seriola dumerili) and isolation of Vibrio bacteriophage

Jin Woo Jun¹, Roberto Bastias¹, Mzia Kutateladze², Marina Tediashvili², Panagiotis Kalatzis¹, Se Chang Park³, Pantelis Katharios¹

¹Institute of Marine Biology, Biotechnology and Aquaculture, Hellenic Centre for Marine Research, Former American Base of Gournes, Heraklion 71003, Crete, Greece

²Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi 0160, Georgia

³Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 151-742, Republic of Korea

HostPhinder: A phage host prediction method

Julia Villarroel¹, Henrike Zschach¹, Kortine Annina Kleinheinz^1,2, Ole Lund¹, Mette Voldby Larsen¹

¹Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, DK-2800 Lyngby, Denmark

²Division of Theoretical Bioinformatics (B080), German Cancer Research Center (DKFZ), Heidelberg, Germany

Simplified Technique for the Production of Soil Bacteriophage Solution for the Prevention of Bacterial Growth on Ground Beef Deliberately Contaminated with E. Coli B: Food Safety and Public Health Applications

Benjamin D Lee

Phoenix Country Day School, 3901 E Stanford Dr, Paradise Valley, AZ 85253 USA

Bacteriophage susceptibility profile of Staphylococcus strains from Romania 

Alina Cristina Neguț 1,2*, Oana Săndulescu 1,2, Anca Streinu-Cercel 1,2, Zemphira Alavidze 3 , Mircea Ioan Popa 1, Adrian Streinu-Cercel 1,2 

1 Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2 National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Bucharest, Romania
3 Phage Therapy Center Tbilisi, Georgia

Isolation and characterization of Clostridium difficile and the bacteriophages from the environment  

Saroa Rashid¹, Andrew Millard² and Martha Clokie¹

¹Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK

² Division of Microbiology and Infection, Warwick Medical School, University of Warwick, Coventry, UK

Purification of Staphylococcus aureus bacteriophages VDX-10 using CIM® monolithic columns

P. Kramberger¹, R. C. Honour², R. E. German²,L. Urbas¹, R. Sekirnik¹

1 BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia

2 Viridax Corporation, 270 NW 3rd Court, Boca Raton, FL 33432-3720 USA

Genomic characterization of the first bacteriophage infecting Arthobacter sp

Eugenijus Simoliunas, Laura Kaliniene, Miroslav Stasilo, Lidija Truncaite, Aurelija Zajanckauskaite and Rolandas Meskys

Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Mokslininku str. 12, Vilnius, Lithuania

Safety and efficacy of topical bacteriophage and EDTA treatment of Staphylococcus aureus infection in a sheep model of sinusitis

Amanda Drilling#, S. Boase#, J. Jervis-Bardy#, C. James*, N. Tan, E. Cleland#, C. Jardeleza#, S. Morales^, A. Smithyman^, S. Vreugde#, P-J Wormald#, P.G. Speck α

#Department of Surgery-Otolaryngology Head and Neck Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia and the University of Adelaide, Adelaide, South Australia, Australia

*Adelaide Pathology Partners, Adelaide, South Australia, Australia

α School of Biological Sciences, Flinders University, Bedford Park, South Australia, Australia

^ Special Phage Services Pty Ltd, New South Wales, Australia

Detection of live Pseudomonas aeruginosa cells using immobilized bacteriophages JG012 and JG024

Christin M Uhlig¹, Julia Garbe², Nina Diekmann³, Sabine Peters³, Ulrich Krause³ and Max Schobert¹

¹Technische Universität Braunschweig, Institute of Microbiology, Spielmannstraße 7, 38106 Braunschweig, Germany

²Department of Clinical Science, Division of Infection Medicine, Lund University, Lund

³AMODIA Bioservice GmbH, Rebenring 31, 38106 Braunschweig, Germany

Towards the treatment of Clostridium difficile infection using SASPject™ technology

Michaella Whittle^1*, Daniela Heeg¹, Sarah A. Kuehne¹, Adam Wilkinson² and Nigel P. Minton¹

¹Clostridia Research Group, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD

²Phico Therapeutics Ltd. Babraham Research Campus, Babraham, Cambridge, CB22 3AT